Cargando…

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice

Herein, Imiquimod (IMQ) was incorporated in nanotransethosomes (nTES) to develop the IMQ-nTES nano-drug delivery system. IMQ-nTES was optimized using 2(3) factorial design. The optimized formulation was expressed with a particle size of 192.4 ± 1.60 nm, Poly-dispersibility of 0.115 ± 0.008, and IMQ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamshaid, Humzah, Din, Fakhar ud, Malik, Maimoona, Mukhtiar, Muhammad, Choi, Han Gon, Ur-Rehman, Tofeeq, Khan, Gul Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392762/ https://www.ncbi.nlm.nih.gov/pubmed/35987944 http://dx.doi.org/10.1038/s41598-022-18671-1

Ejemplares similares

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
por: Alessi, Sabrina Sisto, et al.
Publicado: (2009)

Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998)

Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana
por: Fuentes-Nava, Gabriela, et al.
Publicado: (2021)

Imiquimod - Its role in the treatment of cutaneous malignancies
por: Bubna, Aditya Kumar
Publicado: (2015)

Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery
por: Panoutsopoulou, Eleni, et al.
Publicado: (2022)

Optical Coherence Tomography as a Valuable Tool for the Evaluation of Cutaneous Kaposi Sarcoma Treated with Imiquimod 5% Cream
por: Cantisani, Carmen, et al.
Publicado: (2023)

GENITAL VITILIGO FOLLOWING USE OF IMIQUIMOD 5% CREAM
por: Zhang, Ruzhi, et al.
Publicado: (2011)

Cutaneous plasmacytoma-like posttransplant lymphoproliferative disorder after renal transplantation with response to imiquimod 5% cream and reduced immunosuppression
por: Traboulsi, Danya, et al.
Publicado: (2019)

Successful treatment of cutaneous adult T-cell leukemia/lymphoma with imiquimod
por: Messer, Alison, et al.
Publicado: (2019)

Old World Cutaneous Leishmaniasis: Successful response to topical imiquimod
por: Llamas-Molina, Jose M., et al.
Publicado: (2022)

Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report
por: Jeon, Hye Chan, et al.
Publicado: (2011)

Treatment of locally advanced cutaneous Merkel cell carcinoma with topical imiquimod
por: Saini, Komal, et al.
Publicado: (2021)

Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
por: Yeh, Jennifer E., et al.
Publicado: (2022)

Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer
por: Garcia-Mouronte, Emilio, et al.
Publicado: (2023)

PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
por: Mehta, Vandana, et al.
Publicado: (2008)

Disseminated Superficial Actinic Porokeratosis on the Face Treated with Imiquimod 5% Cream
por: Riad, Hassan, et al.
Publicado: (2013)

Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
por: Yokoyama, Maiko, et al.
Publicado: (2019)

Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report
por: Benomar, Sophia, et al.
Publicado: (2009)

Efficacy of 5% Imiquimod Cream on Vulvar Intraepithelial Neoplasia in Korea: Pilot Study
por: Kim, Jeong-Min, et al.
Publicado: (2015)

Early Treatment with Imiquimod 5% Cream of Periungual Warts in Vietnam: The Poorer, the Better
por: Minh, Phuong Pham Thi, et al.
Publicado: (2019)

Vitiligo-Like Depigmentation following Treatment with Imiquimod 5% Cream for Condylomata Acuminata
por: Alatabani, Maram, et al.
Publicado: (2021)

A case report of imiquimod topical therapy as treatment for cutaneous metastasis of breast cancer
por: Nguyen, Anthony L, et al.
Publicado: (2021)

Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
por: Zhang, Xiaoyan, et al.
Publicado: (2023)

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream
por: Torres, Abel, et al.
Publicado: (2007)

Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
por: Kopera, Daisy, et al.
Publicado: (2014)

Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream
por: Gregersen, Pernille Axél, et al.
Publicado: (2010)

Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
por: Singal, Archana, et al.
Publicado: (2016)

Therapeutic Efficacies of Artemisia capillaris Extract Cream Formulation in Imiquimod-Induced Psoriasis Models
por: Lee, Song Yi, et al.
Publicado: (2018)

Long-Term Follow-Up of Lentigo Maligna Patients Treated with Imiquimod 5% Cream
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2023)

Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient
por: Imashuku, Shinsaku, et al.
Publicado: (2018)

Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight
por: Jamshaid, Humzah, et al.
Publicado: (2021)

Effect of Imiquimod on Tachyzoites of Toxoplasma gondii and Infected Macrophages in vitro and in BALB/c Mice
por: Zaki, Leila, et al.
Publicado: (2020)

Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
por: Hoyme, U B, et al.
Publicado: (2002)

Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
por: Held, Laura, et al.
Publicado: (2013)

Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream
por: Kim, Na Hee, et al.
Publicado: (2018)

Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area
por: Karabulut, Gamze Ozturk, et al.
Publicado: (2017)

Successful treatment of a keratoacanthoma in a young patient with the application of topical 5% imiquimod cream
por: Plachouri, Kerasia‐Maria, et al.
Publicado: (2021)

Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75%
por: Toso, Francesco, et al.
Publicado: (2022)

Diagnostic and Treatment Strategies for COVID-19
por: Jamshaid, Humzah, et al.
Publicado: (2020)

Antipsoriatic Effects of Wannachawee Recipe on Imiquimod-Induced Psoriasis-Like Dermatitis in BALB/c Mice
por: Na Takuathung, Mingkwan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_27et1mi3ko055cfkjj7un7gkie